Evidence map›Paper›PMID 42473635›Full record

ArticleInfectious Disease Modelling2027

Efficacy versus coverage: population-level impacts of vaccination schemes.

Lixin Lin, Lewi Stone

Abstract read
In one paragraph

Article in Infectious Disease Modelling, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lixin LinMathematical Sciences, School of Science, RMIT University, Melbourne, Australia.
Lewi StoneMathematical Sciences, School of Science, RMIT University, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effectiveness of vaccination campaigns depends on vaccine efficacy, vaccination coverage, and vaccine allocation. A fundamental yet often overlooked question is whether higher vaccine efficacy or higher coverage should be prioritised. Here, within a leaky vaccine framework, we provide a theoretical analysis of their relative impact on reducing the epidemic final size in both homogeneous and heterogeneous populations, under proportional and optimal vaccine allocations. We prove that, when vaccine efficacy (in reducing susceptibility) and coverage are traded off so that their product

Indexed as

Attack rateEpidemicHeterogeneity in susceptibilityVaccination coverageVaccine efficacyVaccines

Identifiers

PMID42473635
PMCPMC13380746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.